The cure rate for [diffuse midline glioma] is less than 1%, and the median overall survival is nine to 11 months,” said Dr.

About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...

Major refugee aid groups sued the Trump administration on Monday over the president's executive order suspending the federal refugee resettlement program and funding for resettlement agencies.

Eden is providing access to a new way for individuals to explore GLP-1 therapy: a compounded semaglutide gummy, available ...

BATON ROUGE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2024. Three-Month ...

While Samsung isn’t set to unveil the Galaxy S25 until next week, many case makers including Rokform have already put their cases up for pre-order. Rokform has its rugged cases available for the ...

Microsoft has created a new engineering organization aimed at accelerating AI infrastructure and software development within the company. According to Bloomberg, Jay Parikh, previously VP and ...